Post by
ChesterLives on Oct 04, 2023 3:08pm
Only 16 short on the interim
And no one seems to care. This apathy is the fruit of making no effort to market or communicate for the past 20 years.
Comment by
ChesterLives on Oct 05, 2023 2:26pm
Leaving Spectral on a derelict and obscure US exchange hasn't helped much either. The valuation really is a shame but easily explainable.
Comment by
mercedesman on Oct 05, 2023 11:10pm
What isn't as obvious is whether this under- promotion and under-listing is intentional, an example of incompetence, or something else ? MM
Comment by
ChesterLives on Oct 06, 2023 9:04am
I have no idea. But spending 2 decades as a 30 cent stock with all the progress they have made is an amazing accomplishment, if you choose to look at it that way.
Comment by
mercedesman on Oct 06, 2023 10:52am
I agree ...for an entity that (finally) brings hope of a new treatment - to the brink of FDA approval, for a leading ICU killer (resulting in the death of almost 10 million people worldwide - each and every year), and for the underlyiing publicly traded entity to go that unnoticed, for so long, is truly an amazing feat ! Someone deserves a pat on the back ! MM
Comment by
Rickkie on Oct 06, 2023 3:21pm
You would think that for humanitarian and ethical reasons, this could have been fast tracked by the FDA years ago. So many lives could have been saved!
Comment by
BayStreetWild on Oct 06, 2023 7:21pm
It has been fast tracked. The FDA couldn't have made it easier. 150 patients and you're still complaining? What would make you happy? 15, 12?
Comment by
ChesterLives on Oct 06, 2023 7:58pm
It has been fast tracked, granted Breakthrough status by the FDA and used 100% safely on hundreds of thousands of patients. Granted, 150 patients wasn't a big ask.
Comment by
Rickkie on Oct 06, 2023 9:11pm
It has been fast tracked. The FDA couldn't have made it easier. 150 patients and you're still complaining? What would make you happy? 15, 12? Actually, yes, if they all looked at the history and cared about people's lives.